Ruixun Biological, based in Suzhou, makes digital PCR instruments, reagents and consumables for molecular diagnostics.
Established in 2017 and based in Suzhou, China, Ruixun Biological develops and manufactures digital PCR instruments, reagents and consumables for molecular diagnostics and genetic testing. Its products include COVID-19 RT-PCR detection kits, microfluidic products and the DropDx-2044 digital PCR system. In December 2024 it closed a Series C2 round led by Rivercity Investment, which will fund clinical registration, European market promotion and new products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in